BlossomHill Therapeutics, Inc.
NASDAQBLSM short interest falls 27% over one week to 148,162 shares as of Sept. 17, though daily demand ticked up 6.9%. Cost to borrow eased to 9.16%, down from 9.86% last week. Availability remains elevated at 263% of short interest.
Snapshot as of 19 Sept 2026
No long-form analysis yet for BLSM. Pulse alerts and the live data picture are available on ORTEX.
Open BLSM on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BLSM — free to start on ORTEX.
Sign up for free →Open BLSM on ORTEX